A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

NCT06092034 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Danon Disease

Interventions

GENETIC: RP-A501

Sponsor

Rocket Pharmaceuticals Inc.